Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam

Abstract

Even without significant differences on outcome at discharge, LEV seems less efficient than VPA to control SE after benzodiazepines. A prospective comparative trial is needed to address this potentially concerning finding.